NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Fuse Oncology

Fuse Oncology

Private
Greensboro, North CarolinaHealthcare & Life Scienceshttps://www.fuseonc.com/

Last Round

VC Round

Sep 8, 2023

Total Funding Raised

$2.95M

Company Overview

Fuse Oncology is an oncology software solutions company that develops AI-powered SaaS solutions to streamline radiation oncology workflows and improve clinical efficiency.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, EHR & EMR, Revenue Cycle, Workflow Automation, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

radiation oncology softwareoncology workflow automationrevenue cycle automationclinical documentation automationhealthcare interoperabilityelectronic medical recordEMRoncology information systemsOISclinical decision supportmedical scribe AIAI revenue integrityhealthcare SaaSmedical billing automationAI scribe

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Fuse Oncology Comparables

Compare Fuse Oncology with similar companies based on industry and business-model similarity.

Fuse Oncology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
OncoLens
77%
Radformation
74%
Shavara
73%

Fuse Oncology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundSep 8, 2023
Series AJun 1, 2023
SeedMay 27, 2022

Key People

Founding team and executive leadership

Benjamin Sintay

Chief Innovation Officer, Co-Founder

Founding Team

James Bauler

Chief Executive Officer

Executive Team

Christel Smith

Chief Technology Officer

Executive Team

Fuse Oncology Investors

Notable investors and investment history

Fuse Oncology investors
InvestorRounds
Northeast Georgia Health VenturesSeries A
Cone Health VenturesSeries A
First Trust Capital PartnersSeed
First Launch Capital FundSeed, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 26, 2025

    Showcased live clinical AI solutions at ASTRO 2025.

  • Mar 13, 2025

    Developing a dedicated application for ACROPath to enhance clinical workflows.

Fuse Oncology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Fuse Oncology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Fuse Oncology's valuation, stock price, and market status.

Firmographic Details

HeadquartersGreensboro, North Carolina
Employee Range28
Year Founded2021
Last FundingSep 8, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.